AON
65
2
GIS
47
-2
ADP
70
2
AEE
66
3
FAST
55
2
VRSN
53
3
VLO
62
2
FFIV
67
3
TRV
36
3
PPL
64
4
TSN
50
2
PNW
66
2
VRSK
59
3
SLG
46
-3
MO
60
3
ORCL
67
2
CB
57
3
CMCSA
41
-9
SYF
83
-2
AFL
53
4
AON
65
2
GIS
47
-2
ADP
70
2
AEE
66
3
FAST
55
2
VRSN
53
3
VLO
62
2
FFIV
67
3
TRV
36
3
PPL
64
4
TSN
50
2
PNW
66
2
VRSK
59
3
SLG
46
-3
MO
60
3
ORCL
67
2
CB
57
3
CMCSA
41
-9
SYF
83
-2
AFL
53
4
Financhill
Back

Frontier Communications Parent Vs. Blueprint Medicines Industry Stock Comparison

Buy
73

FYBR
Frontier Communications Parent

Last Price:
$36.49
Seasonality Move:
3.64%
Sell
50

BPMC
Blueprint Medicines

Last Price:
$128.39
Seasonality Move:
7.99%
Buy
73
Frontier Communications Parent (FYBR) is a Buy

Is Frontier Communications Parent a Buy, Sell or Hold?

  • The current Frontier Communications Parent [FYBR] share price is $36.50. The Score for FYBR is 73, which is 46% above its historic median score of 50, and infers lower risk than normal.
  • FYBR is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
50
Blueprint Medicines (BPMC) is a Sell

Is Blueprint Medicines a Buy, Sell or Hold?

  • The current Blueprint Medicines [BPMC] share price is $128.35. The Score for BPMC is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
  • BPMC is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

FYBR Stock Price Chart

What is Frontier Communications Parent's stock price today?

  • The Frontier Communications Parent share price today is $36.50
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and FYBR is experiencing slight selling pressure.

BPMC Stock Price Chart

What is Blueprint Medicines's stock price today?

  • The Blueprint Medicines share price today is $128.35
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BPMC is experiencing slight buying pressure.

FYBR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.02 Buy
Relative Strength Index (14 RSI): 60.62 Buy
Chaikin Money Flow: -302688 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (36.19 - 36.41) Buy
Bollinger Bands (100): (35.8 - 36.44) Buy

BPMC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 4.65 Buy
Relative Strength Index (14 RSI): 74.59 Buy
Chaikin Money Flow: 675123 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (119 - 133.06) Buy
Bollinger Bands (100): (84.56 - 117) Buy

FYBR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 36.39 Buy
20-day SMA: 36.29 Buy
50-day SMA: 36.4 Buy
200-day SMA: 35.69 Buy
8-day EMA: 36.4 Buy
20-day EMA: 36.35 Buy
50-day EMA: 36.29 Buy
200-day EMA: 34.51 Buy

BPMC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 128.23 Buy
20-day SMA: 128.14 Buy
50-day SMA: 111.57 Buy
200-day SMA: 97.6 Buy
8-day EMA: 128.16 Buy
20-day EMA: 125.23 Buy
50-day EMA: 115.07 Buy
200-day EMA: 100.77 Buy

Frontier Communications Parent Earnings Growth & FYBR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.05 per share, an increase next quarter of $0.02 per share, an increase this year of $0.16 per share, and an increase next year of $0.04 per share.

Blueprint Medicines Earnings Growth & BPMC Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.67 per share, an increase next quarter of $0.33 per share, an increase this year of $0.60 per share, and an increase next year of $1.50 per share.

Frontier Communications Parent Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Blueprint Medicines Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):